Factors involved in the enhanced efficacy against gram-negative bacteria of fourth generation cephalosporins.
about
beta-Lactamases in laboratory and clinical resistanceCefepimePharmacokinetics and pharmacodynamics of cefpirome in subcutaneous adipose tissue of septic patients.Detection of extended-spectrum beta-lactamases in clinical isolates of Enterobacter cloacae and Enterobacter aerogenes.Nosocomial outbreak due to a multiresistant strain of Pseudomonas aeruginosa P12: efficacy of cefepime-amikacin therapy and analysis of beta-lactam resistanceIn vitro activities of cephalosporins and quinolones against Escherichia coli strains isolated from diarrheic dairy calvesPharmacokinetics of cefepime during continuous renal replacement therapy in critically ill patients.Comparable population pharmacokinetics and pharmacodynamic breakpoints of cefpirome in cystic fibrosis patients and healthy volunteers.Differences in the resistant variants of Enterobacter cloacae selected by extended-spectrum cephalosporinsPharmacokinetics of cefepime during continuous venovenous hemodiafiltrationHydrolysis spectrum extension of CMY-2-like β-lactamases resulting from structural alteration in the Y-X-N loop.Resistance to cefepime and cefpirome due to a 4-amino-acid deletion in the chromosome-encoded AmpC beta-lactamase of a Serratia marcescens clinical isolate.Optimization of the biotechnological production of a novel class of anti-MRSA antibiotics from Chitinophaga sancti.Interactions of beta-lactamases with sanfetrinem (GV 104326) compared to those with imipenem and with oral beta-lactams.Mutational replacement of Leu-293 in the class C Enterobacter cloacae P99 beta-lactamase confers increased MIC of cefepime.Uptake of cefepime by phagocytosing polymorphonuclear neutrophils and subsequent intracellular killing.Selection during cefepime treatment of a new cephalosporinase variant with extended-spectrum resistance to cefepime in an Enterobacter aerogenes clinical isolateDisposition kinetics and urinary excretion of cefpirome after intravenous injection in buffalo calves.In vitro antimicrobial activity of cefpirome against ceftazidime-resistant isolates from two multicenter studies.Potential of high-dose cefepime/tazobactam against multiresistant Gram-negative pathogens.In vitro activity of cefpirome against selected clinical enterobacterial isolates with beta-lactamase-mediated resistance.Multicentre comparative study on the antibacterial activity of FK-037, a new parenteral cephalosporin.
P2860
Q24669605-889B2E65-AC29-4D6D-8C12-394A3339398AQ29040262-885B9686-D2C9-42A9-A9C6-459F56B98B50Q33802909-1118F75B-0A7D-440B-B432-66B5B7F80573Q33965292-5A22BD4D-72BE-4D3D-A9B9-27387DB63826Q33972470-B450A348-FC6B-475F-8992-1D28D78DB449Q33976394-72EDCAD8-55A4-4749-AAEA-7907B8F3F675Q33983364-2A376F4F-9D2A-45A4-A89D-3F5BF84BAFFBQ35005118-783B0163-16B1-47D3-8DC0-52A2628CBD1EQ35124590-D0A2454B-615E-400C-B8AC-E66400C95191Q35138871-A90D4126-C6C5-4988-B19C-F2374B916192Q35806387-DF9E200E-7399-4307-B908-D7499E5A84E6Q36491987-0D047238-A9E4-40C9-9DDA-D5C06642264BQ38640838-22349506-170F-4D52-993F-93ED5B67D4E1Q39558488-65ED4ECE-F8CB-45F4-A827-DA1FEE1F1ED9Q39651911-67EE9398-A614-4809-AFB9-DC6EF38B61A5Q39782590-D8C7BFD9-5A79-4F8B-9514-46BD675F3903Q40622081-B455F09E-0EC5-4AFE-92ED-D56279CC21B1Q40639279-C9EC07AB-FADD-4CA6-AACE-8F9CB3EF90BEQ44580393-E96F7625-D59A-442F-93F1-EEBAC61870FBQ50069002-E7B58322-4A22-4DA0-82F3-5F2C15C512F0Q54158188-3EA6A032-90B4-4098-86EF-8833C933B286Q54179449-4789B8F1-4B87-4571-99F7-82E4D2FBA039
P2860
Factors involved in the enhanced efficacy against gram-negative bacteria of fourth generation cephalosporins.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Factors involved in the enhanc ...... rth generation cephalosporins.
@ast
Factors involved in the enhanc ...... rth generation cephalosporins.
@en
type
label
Factors involved in the enhanc ...... rth generation cephalosporins.
@ast
Factors involved in the enhanc ...... rth generation cephalosporins.
@en
prefLabel
Factors involved in the enhanc ...... rth generation cephalosporins.
@ast
Factors involved in the enhanc ...... rth generation cephalosporins.
@en
P356
P1476
Factors involved in the enhanc ...... rth generation cephalosporins.
@en
P2093
P356
10.1093/JAC/29.SUPPL_A.1
P407
P478
29 Suppl A
P577
1992-04-01T00:00:00Z